Over the last 14 years Rodon Biologics (previously branded as Biotecnol SA) has successfully completed numerous product and process development projects for different stages in the drug development cycle, from research to clinical trial Phase III.
Partner led-programs have been undertaken on behalf of small, mid and large size biotechnology and pharma companies for a wide range of different molecule types including cytokines, growth factors, immunotoxins, antigens, antibodies, antibody fragments and multispecific antibody based formats.
Clients receive products that better fit their needs. Rodon Biologics offers a new service matrix that in addition to Process Development / Manufacturing also includes stand alone services supporting preliminary research activities and tools in addition to preclinical and clinical development.